Concord Medical Co (ROCO:6518) EPS (Basic): NT$2.02 (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6518 Concord Medical Co Ltd ROCO:6518
71 GF Score
Price NT$30.40
GF Value NT$29.15
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Concord Medical Co EPS (Basic)?

Concord Medical Co ROCO:6518 -0.65% 71 EPS (Basic) is NT$2.02 as of Dec. 2025. GuruFocus rates ROCO:6518 with a GF Score™ of 71/100 and a GF Value™ of NT$29.15 (Fairly Valued). The stock has 3 warning signs investors should review.

Concord Medical Co's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was NT$1.15. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$2.02.

Concord Medical Co's EPS (Diluted) for the six months ended in Dec. 2025 was NT$1.14. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$2.01.

Concord Medical Co's EPS without NRI for the six months ended in Dec. 2025 was NT$1.14. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 2.01.

During the past 12 months, Concord Medical Co's average EPS without NRIGrowth Rate was 33.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was 10.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 15.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 18.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Concord Medical Co's highest 3-Year average EPS without NRI Growth Rate was 197.10% per year. The lowest was -71.00% per year. And the median was 10.60% per year.

Concord Medical Co  (ROCO:6518) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Concord Medical Co EPS (Basic) Related Terms

Concord Medical Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Concord Medical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Concord Medical Co EPS (Basic) Chart

Concord Medical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.37 1.52 1.28 1.49 2.02

Concord Medical Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 0.71 0.78 0.87 1.15
ROCO:6518
71GF Score
Concord Medical Co Ltd ROCO:6518
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Concord Medical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Concord Medical Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(67.364-0)/33.333
=2.02

Concord Medical Co's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(38.419-0)/33.333
=1.15

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$2.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of NT$2.02 mean?
Concord Medical Co (ROCO:6518) has a EPS (Basic) of NT$2.02 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Concord Medical Co and its competitors.
Is Concord Medical Co's EPS (Basic) too high?
Concord Medical Co's current EPS (Basic) is NT$2.02. Overall, Concord Medical Co has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Concord Medical Co's EPS (Basic) compare to ISRG and BDX?
Concord Medical Co's EPS (Basic) of NT$2.02 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Concord Medical Co and its competitors. Concord Medical Co's current EPS (Basic) is NT$2.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Concord Medical Co (ROCO:6518) is currently considered Fairly Valued. The stock's GF Value™ is NT$29.15, compared to a current price of NT$30.40 — trading 4.3% above its estimated fair value. The current EPS (Basic) is NT$2.02. Concord Medical Co's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Concord Medical Co (ROCO:6518), the current EPS (Basic) is NT$2.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Concord Medical Co (ROCO:6518) Overvalued in 2026?

Based on GuruFocus' analysis, Concord Medical Co stock appears to be overvalued. The current stock price of NT$30.40 is trading 4.3% above its estimated GF Value™ of NT$29.15. GuruFocus considers Concord Medical Co to be Fairly Valued.

Key valuation signals for ROCO:6518:

  • EPS (Basic): NT$2.02
  • GF Value™: NT$29.15 vs. price of NT$30.40 (4.3% above fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6518 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Concord Medical Co Business Description

Address Number 266, Wenhua Road, 12F, Sec.1, 12th Floor, Banqiao District, New Taipei City, Taipei, TWN, 22041
Concord Medical Co Ltd is a Taiwan based company involved in providing hospital management support services including medical equipment leasing, pharmaceuticals, and medical consumables integrated supply. . The company's main business items are medical equipment, pharmaceuticals Product trading business, leasing business and management consulting services.
71GF Score

Get the complete analysis for ROCO:6518

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$30.40
Price
NT$29.15
GF Value